Skip to main content
HealthSingle-sourceLow
2.1

Gabather reports reduced operating losses for Q2 2026

Swedish biotech firm Gabather reported an operating loss of 1.0 million SEK for Q2 2026, an improvement from the 1.3 million SEK loss in the same period last year. The company continues its focus on developing drug candidates for mental health disorders.

Dagens Industriabout 4 hours agoSECredibility 27%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.3

Intelligence Tags

Locations

Sweden

Entities

country
Source

Related signals

8 found